CANOPY GROWTH CORP (WEED.CA) Stock Fundamental Analysis

TSX:WEED • CA1380357048

1.45 CAD
-0.04 (-2.68%)
Last: Feb 11, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

Overall WEED gets a fundamental rating of 2 out of 10. We evaluated WEED against 33 industry peers in the Pharmaceuticals industry. The financial health of WEED is average, but there are quite some concerns on its profitability. WEED does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • WEED had negative earnings in the past year.
  • In the past year WEED has reported a negative cash flow from operations.
  • In the past 5 years WEED always reported negative net income.
  • WEED had a negative operating cash flow in each of the past 5 years.
WEED.CA Yearly Net Income VS EBIT VS OCF VS FCFWEED.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -1B -2B -3B

1.2 Ratios

  • WEED has a Return On Assets of -36.07%. This is in the lower half of the industry: WEED underperforms 69.70% of its industry peers.
  • The Return On Equity of WEED (-52.42%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -36.07%
ROE -52.42%
ROIC N/A
ROA(3y)-83.37%
ROA(5y)-56.25%
ROE(3y)-219.63%
ROE(5y)-143.17%
ROIC(3y)N/A
ROIC(5y)N/A
WEED.CA Yearly ROA, ROE, ROICWEED.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -100 -200 -300 -400

1.3 Margins

  • With a Gross Margin value of 27.49%, WEED is not doing good in the industry: 60.61% of the companies in the same industry are doing better.
  • The Profit Margin and Operating Margin are not available for WEED so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 27.49%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
WEED.CA Yearly Profit, Operating, Gross MarginsWEED.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200 -400 -600 -800

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • WEED does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • WEED has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, WEED has less shares outstanding
  • Compared to 1 year ago, WEED has an improved debt to assets ratio.
WEED.CA Yearly Shares OutstandingWEED.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M
WEED.CA Yearly Total Debt VS Total AssetsWEED.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

  • WEED has an Altman-Z score of -9.50. This is a bad value and indicates that WEED is not financially healthy and even has some risk of bankruptcy.
  • WEED's Altman-Z score of -9.50 is on the low side compared to the rest of the industry. WEED is outperformed by 78.79% of its industry peers.
  • WEED has a Debt/Equity ratio of 0.33. This is a healthy value indicating a solid balance between debt and equity.
  • WEED's Debt to Equity ratio of 0.33 is in line compared to the rest of the industry. WEED outperforms 51.52% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF N/A
Altman-Z -9.5
ROIC/WACCN/A
WACC10.94%
WEED.CA Yearly LT Debt VS Equity VS FCFWEED.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B

2.3 Liquidity

  • WEED has a Current Ratio of 5.50. This indicates that WEED is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Current ratio value of 5.50, WEED belongs to the best of the industry, outperforming 96.97% of the companies in the same industry.
  • WEED has a Quick Ratio of 4.23. This indicates that WEED is financially healthy and has no problem in meeting its short term obligations.
  • WEED has a better Quick ratio (4.23) than 96.97% of its industry peers.
Industry RankSector Rank
Current Ratio 5.5
Quick Ratio 4.23
WEED.CA Yearly Current Assets VS Current LiabilitesWEED.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 64.81% over the past year.
  • The Revenue has decreased by -9.47% in the past year.
  • The Revenue has been decreasing by -7.57% on average over the past years.
EPS 1Y (TTM)64.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%87.68%
Revenue 1Y (TTM)-9.47%
Revenue growth 3Y-19.22%
Revenue growth 5Y-7.57%
Sales Q2Q%-2.17%

3.2 Future

  • Based on estimates for the next years, WEED will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.29% on average per year.
  • Based on estimates for the next years, WEED will show a small growth in Revenue. The Revenue will grow by 6.42% on average per year.
EPS Next Y94.65%
EPS Next 2Y40.65%
EPS Next 3Y25.38%
EPS Next 5Y15.29%
Revenue Next Year2.14%
Revenue Next 2Y4.71%
Revenue Next 3Y30.84%
Revenue Next 5Y6.42%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
WEED.CA Yearly Revenue VS EstimatesWEED.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M
WEED.CA Yearly EPS VS EstimatesWEED.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 -20 -40 -60

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for WEED. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for WEED. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
WEED.CA Price Earnings VS Forward Price EarningsWEED.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
WEED.CA Per share dataWEED.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1

4.3 Compensation for Growth

  • WEED's earnings are expected to grow with 25.38% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.65%
EPS Next 3Y25.38%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • WEED does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CANOPY GROWTH CORP

TSX:WEED (2/11/2026, 7:00:00 PM)

1.45

-0.04 (-2.68%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-06
Earnings (Next)05-28
Inst Owners11.18%
Inst Owner ChangeN/A
Ins Owners0.18%
Ins Owner ChangeN/A
Market Cap534.27M
Revenue(TTM)269.00M
Net Income(TTM)-385.85M
Analysts47.69
Price Target3.44 (137.24%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)51.01%
Min EPS beat(2)8.22%
Max EPS beat(2)93.8%
EPS beat(4)2
Avg EPS beat(4)-51.44%
Min EPS beat(4)-206.63%
Max EPS beat(4)93.8%
EPS beat(8)2
Avg EPS beat(8)-152.68%
EPS beat(12)3
Avg EPS beat(12)-166.46%
EPS beat(16)4
Avg EPS beat(16)-163.73%
Revenue beat(2)1
Avg Revenue beat(2)0.9%
Min Revenue beat(2)-7.76%
Max Revenue beat(2)9.57%
Revenue beat(4)3
Avg Revenue beat(4)3.88%
Min Revenue beat(4)-7.76%
Max Revenue beat(4)9.57%
Revenue beat(8)5
Avg Revenue beat(8)2.85%
Revenue beat(12)6
Avg Revenue beat(12)1.1%
Revenue beat(16)8
Avg Revenue beat(16)-0.85%
PT rev (1m)-11.18%
PT rev (3m)-8.78%
EPS NQ rev (1m)0%
EPS NQ rev (3m)66.67%
EPS NY rev (1m)-4.09%
EPS NY rev (3m)53.1%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-8.94%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5.7%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.92
P/FCF N/A
P/OCF N/A
P/B 0.73
P/tB 0.88
EV/EBITDA N/A
EPS(TTM)-1.84
EYN/A
EPS(NY)-0.12
Fwd EYN/A
FCF(TTM)-0.26
FCFYN/A
OCF(TTM)-0.24
OCFYN/A
SpS0.76
BVpS2
TBVpS1.65
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -36.07%
ROE -52.42%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 27.49%
FCFM N/A
ROA(3y)-83.37%
ROA(5y)-56.25%
ROE(3y)-219.63%
ROE(5y)-143.17%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.26
Health
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 18.94%
Cap/Sales 2.77%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.5
Quick Ratio 4.23
Altman-Z -9.5
F-Score5
WACC10.94%
ROIC/WACCN/A
Cap/Depr(3y)15.39%
Cap/Depr(5y)45.04%
Cap/Sales(3y)2.72%
Cap/Sales(5y)9.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)64.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%87.68%
EPS Next Y94.65%
EPS Next 2Y40.65%
EPS Next 3Y25.38%
EPS Next 5Y15.29%
Revenue 1Y (TTM)-9.47%
Revenue growth 3Y-19.22%
Revenue growth 5Y-7.57%
Sales Q2Q%-2.17%
Revenue Next Year2.14%
Revenue Next 2Y4.71%
Revenue Next 3Y30.84%
Revenue Next 5Y6.42%
EBIT growth 1Y51.22%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year89.39%
EBIT Next 3Y31%
EBIT Next 5Y20.1%
FCF growth 1Y81.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y82.69%
OCF growth 3YN/A
OCF growth 5YN/A

CANOPY GROWTH CORP / WEED.CA FAQ

Can you provide the ChartMill fundamental rating for CANOPY GROWTH CORP?

ChartMill assigns a fundamental rating of 2 / 10 to WEED.CA.


Can you provide the valuation status for CANOPY GROWTH CORP?

ChartMill assigns a valuation rating of 1 / 10 to CANOPY GROWTH CORP (WEED.CA). This can be considered as Overvalued.


How profitable is CANOPY GROWTH CORP (WEED.CA) stock?

CANOPY GROWTH CORP (WEED.CA) has a profitability rating of 0 / 10.


Can you provide the expected EPS growth for WEED stock?

The Earnings per Share (EPS) of CANOPY GROWTH CORP (WEED.CA) is expected to grow by 94.65% in the next year.